CytRx Corporation

(CYTR) Trade

By |

Profile

CytRx Corp is a biopharmaceutical research and development company in the United States. Its key drug candidate is aldoxorubicin, which is developed to address serious diseases such as soft tissue sarcoma (STS).

Contact Information

Website: www.cytrx.com
Email: info@cytrx.com
Main Phone: +1 310 826-5648
Address: 11726 San Vicente Boulevard
Address 2: Suite 650
State: CA
City / Town: Los Angeles
Country: USA
Postal Code: 90049

Issuer Information

Exchange: NSC
CEO: Steven A. Kriegsman
Employees: 20
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)
$ 1.07 $ 0.02 (1.90%)
Last Price 1.07 Change $ 0.02 Change % 1.90 Tick N/A
Bid 1.06 Bid Size 100.00 Ask 1.07 Ask Size 5,500.00
Open 1.04 High 1.07 Low 1.04 Prev Close 1.05
Last Trade Volume 32,819 52 Wk Hi 2.59 52 Wk Low 0.31
Market Cap 36 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 33,637,501.00 EPS (TTM) -0.57 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 1
Number of Buys 0 1
Number of Sells 0 0
Net Activity 0 387597
Last 10 Buys Shares
Steven A. Kriegsman 1,000
Richard L. Wennekamp 1,000
John Y. Caloz 1,000
Max E. Link 1,000
Steven A. Kriegsman 1,000
Daniel J. Levitt 1,000
Richard L. Wennekamp 1,000
Marvin R. Selter 1,000
John Y. Caloz 1,000
Max E. Link 1,000
Last 10 Sell Shares
N/A 0
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 4.5 4.5 4.5 4.5
Low Target Price Estimate 4.5 4.5 4.5 4.5
Mean Target Price Estimate 4.5 4.5 4.5 4.5
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 05/23/18 05/23/18 05/23/18 05/23/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 1 0 0
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 0 0